Desouzara, I agree with Tombeau, an acquirer will have to pay very good money to acquire PME, but everything is for sale at a price. The points you raise are correct but also make the business very appealing for one of the bigger US healthcare players looking for new product and applications growth.
Ann: PME appoints new Non-Executive Director-PME.AX, page-4
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$227.64 |
Change
5.890(2.66%) |
Mkt cap ! $17.90B | |||
| Open | High | Low | Value | Volume |
| $225.00 | $229.57 | $223.37 | $80.03M | 351.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4 | $227.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $227.72 | 3210 | 3 |
View Market Depth
| Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
| PME (ASX) Chart |
